← Open Payments lookup

WENDY GAMMON: Open Payments

NPI 1669848156 · TEXARKANA, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$283 in 15 payments from 10 companies in 2025. Trend: 2023 $531 · 2024 $644 · 2025 $283

Food & beverage: $283
CompanyPaymentsAmount
Currax Pharmaceuticals LLC3$50
Novo Nordisk Inc2$43
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$39
Lilly USA, LLC2$33
ABBVIE INC.1$28
Axsome Therapeutics, Inc.1$24
E.R. Squibb & Sons, L.L.C.1$19
PFIZER INC.1$18
Otsuka America Pharmaceutical, Inc.1$15
AstraZeneca Pharmaceuticals LP1$15

Products named: CONTRAVE, Wegovy, CAPLYTA, MOUNJARO, VRAYLAR, Auvelity, COBENFY, ELIQUIS.

Industry payments across AR — which companies pay providers there.